These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 6223793
21. Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial. Hodinka RL, Jack-Wait K, Wannamaker N, Walden TP, Gilligan PH. Eur J Clin Microbiol; 1987 Feb; 6(1):100-3. PubMed ID: 3032607 [Abstract] [Full Text] [Related]
22. A comparison of the responses of staphylococci and streptococci to teicoplanin and vancomycin. Greenwood D, Bidgood K, Turner M. J Antimicrob Chemother; 1987 Aug; 20(2):155-64. PubMed ID: 2959642 [Abstract] [Full Text] [Related]
23. Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007). Biedenbach DJ, Jones RN. Diagn Microbiol Infect Dis; 2009 Jun; 64(2):177-84. PubMed ID: 19249179 [Abstract] [Full Text] [Related]
24. The in-vitro activity of some antimicrobial agents against methicillin-resistant Staphylococcus aureus. Moorhouse EC, Mulvihill TE, Jones L, Mooney D, Falkiner FR, Keane CT. J Antimicrob Chemother; 1985 Mar; 15(3):291-5. PubMed ID: 3158632 [Abstract] [Full Text] [Related]
25. In vitro activity of teicoplanin against gram-positive cocci. Allouch P, Pina P, Chaplain C, Delarbre JM, Geffroy F, Grasmick CP, Marcolin M, Morel A, Pangon B, Rio Y, Sédaillan A. Pathol Biol (Paris); 2000 Oct; 48(8):792-5. PubMed ID: 11244609 [Abstract] [Full Text] [Related]
26. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011. Morrissey I, Seifert H, Canton R, Nordmann P, Stefani S, Macgowan A, Janes R, Knight D, Oritavancin Study Group. J Antimicrob Chemother; 2013 Jan; 68(1):164-7. PubMed ID: 22941898 [Abstract] [Full Text] [Related]
27. In-vitro bactericidal activity of cefpirome in combination with vancomycin against Staphylococcus aureus and coagulase-negative staphylococci. Raymond J, Vedel G, Bergeret M. J Antimicrob Chemother; 1996 Dec; 38(6):1067-71. PubMed ID: 9023655 [Abstract] [Full Text] [Related]
28. [The invitro activity of teicoplanin and vancomycin against gram positive microorganisms (corrected)]. Kayaokay Y, Hasçelik G, Gür D, Akalin E. Mikrobiyol Bul; 1991 Oct; 25(4):321-5. PubMed ID: 1839050 [Abstract] [Full Text] [Related]
29. Comparative in vitro activity of the new oxazolidinones DuP 721 and DuP 105 against staphylococci and streptococci. Mini E, Novelli A, Mazzei T, Periti P. Eur J Clin Microbiol Infect Dis; 1989 Mar; 8(3):256-60. PubMed ID: 2523807 [Abstract] [Full Text] [Related]
30. Evaluation of in vitro activity of teicoplanin against recent clinical isolates. Nani E, Amato G, Anzivino D, Covelli B, Lembo M. Chemioterapia; 1988 Feb; 7(1):20-3. PubMed ID: 2967737 [Abstract] [Full Text] [Related]
31. In vitro activity of teicoplanin and vancomycin against gram-positive bacteria from human clinical and veterinary sources. Jensen KT, Schønheyder H, Pers C, Thomsen VF. APMIS; 1992 Jun; 100(6):543-52. PubMed ID: 1535201 [Abstract] [Full Text] [Related]
32. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)]. Loza E, Morosini MI, Pascual A, Tubau F, Alcalá J, Liñares J, Hernández-Bello JR, Baquero F, Perea E, Martín R, Jones RN, Cantón R, SENTRY Surveillance Program, Spain (2002-2006). Enferm Infecc Microbiol Clin; 2008 Oct; 26(8):489-94. PubMed ID: 19094861 [Abstract] [Full Text] [Related]
33. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin. Pohlod DJ, Saravolatz LD, Somerville MM. J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646 [Abstract] [Full Text] [Related]
34. Bactericidal activity of teicoplanin in an in-vitro two-compartment kinetic model. Pallanza R, Scotti R, Arioli V. J Antimicrob Chemother; 1988 Jan; 21 Suppl A():15-21. PubMed ID: 2965127 [Abstract] [Full Text] [Related]
35. In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients. Rolston KV, Wang W, Nesher L, Shelburne SA, Prince RA. J Antibiot (Tokyo); 2016 May; 69(5):381-7. PubMed ID: 26626876 [Abstract] [Full Text] [Related]
36. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics. Debbia E, Schito GC, Nicoletti G, Speciale A. Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779 [Abstract] [Full Text] [Related]
37. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin. Maskell JP, Sefton AM, Yong J, Chi SJ, Williams JD. Infection; 1988 Oct; 16(6):365-70. PubMed ID: 3146552 [Abstract] [Full Text] [Related]
38. Comparative in vitro activity of linezolid and five other antimicrobials against nosocomial isolates of methicillin-resistant Staphylococcus aureus, methicillin-resistant Staphylococcus epidermidis and vancomycin-resistant Enterococcus faecium. Metallidis S, Chatzidimitriou M, Nikolaidis P, Tsona A, Bisiklis A, Kollaras P, Tsiakiri E, Koumentaki E, Alexiou-Daniel S. J Chemother; 2003 Oct; 15(5):442-8. PubMed ID: 14603881 [Abstract] [Full Text] [Related]
39. Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol. Jones RN, Fritsche TR, Sader HS, Goldstein BP. J Chemother; 2005 Dec; 17(6):593-600. PubMed ID: 16433188 [Abstract] [Full Text] [Related]
40. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin. Sader HS, Fritsche TR, Jones RN. Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]